Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Feb;26(2):105-8.
doi: 10.1046/j.1524-4725.2000.98012.x.

Sclerotherapy for treatment of hemangiomas

H Winter  1 , E Dräger, W Sterry
Affiliations

Sclerotherapy for treatment of hemangiomas

H Winter et al. Dermatol Surg. 2000 Feb.

Abstract

Background: While sclerotherapy in chronic venous insufficiency and in hemorrhoids is well established, the use of sclerotherapy for hemangiomas of the skin is widely unknown.

Objective: The aim of the study was to analyze the clinical value of sclerotherapy with polidocanol in a larger population.

Methods: Over a period of 20 years (1975-1995) we performed sclerotherapy of hemangiomas and vascular malformations in a total of 157 patients. Their ages ranged from 3 months to 75 years. Among these were 87 (55.4%) children and adolescents (up to the age of 18). Sclerotherapy with polidocanol was carried out mostly at monstrous or rapidly growing cavernous hemangiomas mainly localized in the face.

Results: One to three injections was usually sufficient to obtain the sclerosis effect; aesthetically, long-term results were convincing. Severe complications were not observed.

Conclusion: Sclerotherapy of hemangiomas is a relatively simple, effective, and inexpensive method that is a valuable and promising treatment.

PubMed Disclaimer